CLINICAL_TRIALS
trial_result
· 2020-08-10
Clinical Trial Update: Ponatinib for FLT3-ITD Acute Myelogenous Leukemia [Phase 1, Phase 2]
Summary
A clinical trial update on ponatinib for FLT3-ITD acute myeloid leukemia, spanning Phase 1 and Phase 2, with unclear status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Versailles Hospital | Conditions: Acute Myeloid Lukemia | Phase 1, Phase 2 | Status: UNKNOWN